Mice transplanted with IL1RL1-deficient MOLM14 cells exhibited prolonged survival and lower leukemia burden (Supplementary Fig. 17B, C) compared to WT MOLM14 recipients at day 10 and 21 post-challenge. This evidence concerns the gene IL1RL1 and leukemia.